Treatment of thyroid-stimulating hormone-secreting adenomas with octreotide
- 30 September 1992
- journal article
- Published by Elsevier in Metabolism
- Vol. 41 (9) , 62-65
- https://doi.org/10.1016/0026-0495(92)90033-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Thyrotropin-Secreting Pituitary Adenomas: Report of Seven CasesJournal of Clinical Endocrinology & Metabolism, 1991
- Surgical treatment of thyrotropin-secreting pituitary adenomasJournal of Neurosurgery, 1990
- Treatment of Hyperthyroidism due to Inappropriate Secretion of Thyrotropin With the Somatostatin Analog SMS 201–995*Journal of Clinical Endocrinology & Metabolism, 1989
- Long Term Treatment With the Somatostatin Analog SMS 201–995 in a Patient With a Thyrotropin- and Growth Hormone-Secreting Pituitary AdenomaJournal of Clinical Endocrinology & Metabolism, 1988
- Response of Thyrotropin-Secreting Pituitary Adenomas to a Long-Acting Somatostatin AnalogueNew England Journal of Medicine, 1987
- Visual Improvement with SMS 201–995 in a Patient with a Thyrotropin-Secreting Pituitary AdenomaNew England Journal of Medicine, 1987
- Inappropriate Secretion of Thyroid-Stimulating HormoneAnnals of Internal Medicine, 1981
- Hyperthyroidism with Elevated Plasma TSH Levels and Pituitary Tumor: Study with SomatostatinJournal of Clinical Endocrinology & Metabolism, 1976
- Inhibition by Somatostatin of Basal Levels of Serum Thyrotropin (TSH) in Normal MenJournal of Clinical Endocrinology & Metabolism, 1975
- Inhibition by Somatostatin on the Release of TSH Induced in Man by Thyrotropin-Releasing FactorJournal of Clinical Endocrinology & Metabolism, 1974